Alliancebernstein L.P. lifted its position in The Beauty Health Company (NASDAQ:SKIN) by 138.6% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 104,273 shares of the company’s stock after purchasing an additional 60,573 shares during the period. Alliancebernstein L.P.’s holdings in Beauty Health were worth $2,708,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the company. Lord Abbett & CO. LLC bought a new position in shares of Beauty Health in the third quarter worth approximately $56,687,000. BlackRock Inc. grew its holdings in shares of Beauty Health by 117.8% in the third quarter. BlackRock Inc. now owns 7,526,320 shares of the company’s stock worth $195,459,000 after purchasing an additional 4,071,277 shares during the last quarter. Jennison Associates LLC grew its holdings in shares of Beauty Health by 375.4% in the third quarter. Jennison Associates LLC now owns 81,749 shares of the company’s stock worth $2,123,000 after purchasing an additional 64,553 shares during the last quarter. Russell Investments Group Ltd. bought a new position in shares of Beauty Health in the third quarter worth approximately $2,094,000. Finally, Advisor Group Holdings Inc. grew its holdings in shares of Beauty Health by 1,093.7% in the third quarter. Advisor Group Holdings Inc. now owns 4,381 shares of the company’s stock worth $113,000 after purchasing an additional 4,014 shares during the last quarter. Hedge funds and other institutional investors own 62.08% of the company’s stock.

SKIN opened at $13.49 on Friday. The stock has a 50-day moving average price of $19.82 and a 200-day moving average price of $23.04. The Beauty Health Company has a 1 year low of $9.71 and a 1 year high of $30.17.

Beauty Health (NASDAQ:SKIN) last posted its quarterly earnings results on Monday, November 8th. The company reported ($1.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by ($1.60). The firm had revenue of $68.15 million during the quarter, compared to analysts’ expectations of $59.57 million. Sell-side analysts forecast that The Beauty Health Company will post -0.09 earnings per share for the current fiscal year.

Several analysts recently weighed in on the stock. William Blair assumed coverage on shares of Beauty Health in a report on Friday, January 7th. They issued an “outperform” rating on the stock. DA Davidson lifted their price target on shares of Beauty Health from $26.00 to $32.00 and gave the company a “buy” rating in a report on Wednesday, November 10th. Raymond James assumed coverage on shares of Beauty Health in a report on Thursday, December 23rd. They issued a “market perform” rating on the stock. Finally, Zacks Investment Research cut shares of Beauty Health from a “buy” rating to a “hold” rating in a report on Saturday, January 29th. Two analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $28.22.

Beauty Health Profile

Edge Systems, LLC designs, develops, manufactures, markets, and sells aesthetic technologies and products. It offers hydradermabrasion system that enhances the skin to cleanse, exfoliate, extract, and hydrate simultaneously; Hydraglucan Intense Hydration Booster, a customization for the HydraFacial treatment exfoliates the skin by improving cell renewal and delivers ingredients, including hyaluronic acid, glucan, and betaine to hydrate the skin and provide anti-aging benefits; HydraFacial Daily Essentials, which provides detoxification, rejuvenation, and protection of skin; crystal microdermabrasion systems; and light emitting diode systems.

Recommended Story: Trading Ex-Dividend

Want to see what other hedge funds are holding SKIN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Beauty Health Company (NASDAQ:SKIN).